Search results
Lab to jab in 100 days: manufacturing flexibility for future rapid responses
The Coalition for Epidemic Preparedness Innovations (CEPI) is on a mission to explore whether new vaccines could be developed against emerging infectious diseases within just 100 days. With ...
Pharmaceutical Technology
3 days ago
Emergent scores US medical countermeasure contracts worth over $250m
The company will supply four products – vaccines for anthrax and smallpox, VIV for treating smallpox vaccine complications, and a botulism antitoxin.
Pharmaceutical Technology
23 hours ago